Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
18 studies found for:    HIV | Open Studies | Netherlands
Show Display Options
Rank Status Study
1 Recruiting Therapeutic HPV-16 Vaccination for the Treatment of Anal Dysplasia
Conditions: Anal Intraepithelial Neoplasia;   HIV
Intervention: Drug: HPV-16 vaccine
2 Recruiting Inhalation/Nasal Corticosteroids and Prevalence of Hypothalamic-pituitary-adrenal (HPA) Axis Suppression in Human Immunodeficiency Virus (HIV)-Patients
Condition: Adrenal Insufficiency
Intervention: Other: ACTH stimulation test
3 Recruiting HPV (Human Papilloma Virus) Vaccination After Treatment of Anal Intraepithelial Neoplasia (AIN)
Conditions: AIN;   HIV
Interventions: Biological: Gardasil;   Drug: Placebo
4 Recruiting Effect of SwitChing AtriPla to Eviplera on Neurocognitive and Emotional Functioning
Conditions: Neurocognitive Decline;   HIV Associated Neurocognitive Disorder
Intervention: Drug: Eviplera
5 Recruiting A SYNdemic BASed INtervention for MSM With High Risk Behavior: Design of a Randomized Controlled Trial
Condition: Risk Behavior
Intervention: Behavioral: Screening and feedback
6 Recruiting Switching From Tenofovir Disoproxil Fumarate to Abacavir or Tenofovir Alafenamide
Conditions: Renal Insufficiency,Chronic;   Hiv;   Therapeutic Agent Toxicity
Interventions: Drug: tenofovir alafenamide;   Drug: abacavir
7 Recruiting iHIVARNA Clinical Trial in HIV Infected Individuals
Condition: HIV Infections
Interventions: Biological: iHIVARNA-01;   Biological: TriMix;   Biological: Placebo
8 Recruiting Pharmacokinetics of Antiretroviral Agents in HIV-infected Pregnant Women.
Condition: HIV Infections
Intervention:
9 Recruiting Dutch Acute HCV in HIV Study (DAHHS-2): Grazoprevir/Elbasvir for Acute HCV
Conditions: Acute Hepatitis C;   Human Immunodeficiency Virus;   Hepatitis C
Intervention: Drug: Grazoprevir/Elbasvir 100mg/50mg
10 Recruiting Placental Passage and Disposition of Drugs: A Physiology-based Approach
Condition: Pregnancy
Intervention:
11 Recruiting The VIBLOK SAfety and perFormancE Trial
Conditions: HSV-2 Infection;   Genital Herpes
Intervention: Device: VIBLOK barrier cream
12 Recruiting Study to Evaluate the Efficacy, Safety, and Tolerability of Long-acting Intramuscular Cabotegravir and Rilpivirine for Maintenance of Virologic Suppression Following Switch From an Integrase Inhibitor in HIV-1 Infected Therapy Naive Participants
Condition: Infection, Human Immunodeficiency Virus
Interventions: Drug: Cabotegravir (CAB) tablet;   Drug: Rilpivirine (RPV) tablet;   Drug: Cabotegravir - Injectable Suspension (CAB LA);   Drug: Rilpivirine - Injectable Suspension (RPV LA);   Drug: ABC/DTG/3TC STR - Tablet;   Drug: DTG Tablet
13 Recruiting Safety and Efficacy of Emtricitabine and Tenofovir Alafenamide (F/TAF) Fixed-Dose Combination Once Daily for Pre-Exposure Prophylaxis in Men and Transgender Women Who Have Sex With Men and Are At Risk of HIV-1 Infection
Condition: Pre-Exposure Prophylaxis of HIV-1 Infection
Interventions: Drug: F/TAF;   Drug: F/TDF;   Drug: F/TAF Placebo;   Drug: F/TDF Placebo
14 Not yet recruiting Randomised Study of Interferon-free Treatment for Recently Acquired Hepatitis C in PWID and People With HIV Coinfection.
Condition: Hepatitis C
Interventions: Drug: SOF/VEL for 6 weeks;   Drug: SOF/VEL for 12 weeks
15 Recruiting Food Effect Study of ModraDoc006 in Combination With Ritonavir
Condition: Solid Tumor, Adult
Intervention: Drug: ModraDoc006/r
16 Not yet recruiting Attain Stability™ Quad Clinical Study
Condition: Heart Failure
Intervention: Device: Attain Stability Quad Pacing Lead
17 Recruiting Efficacy and Safety Study of Mongersen (GED-0301) for the Treatment of Subjects With Active Crohn's Disease
Condition: Crohn Disease
Interventions: Drug: GED-0301;   Drug: Placebo
18 Recruiting A Long-term Active Treatment Study of Mongersen (GED-0301) in Subjects With Crohn's Disease
Condition: Crohn's Disease
Interventions: Drug: GED-0301;   Other: Placebo

Study has passed its completion date and status has not been verified in more than two years.